[1] Yoo HS, Lee KH, Oh JE, et al. in vitro and in vivo anti-tumor activities of nanoparticles based on doxorubicin-PLGA conjugates[J]. J Control Rel, 2000, 68(3): 419-26.
[2] Torres EC, Rodrigues JM, Moreira DL, et al. Improvement of in vitro and in vivo antileishmanial activities of 2’, 6’-dihydroxy-4’ -methoxychalcone by entrapment in poly(D, L-lactide)nanoparticles[J]. Antimicrob Agents Chemother, 1999, 43(7): 1776-82.
[3] Sershen SR, Westcott SL, Halas NJ, et al. Temperature-sensitive Polymer nanoshell composites for photothermally modulated drug delivery[J]. J Biomed Mater Res, 2000, 51(3): 293-300.
[4] Roy K, Mao HQ, Huang SK, et al. Oral gene delivery with chitosan DNA nanoparticles generates immunologic protection in a murine model of peanut allergy[J]. Nat Med, 1999, 5(4): 387-95.
[5] Schwarz C, Mehnert W. Solid liquid nanoparticles(SLN) for control led-drug delivery Ⅱ. Drug incorpouation and physicochemical chara cterization[J]. J Microencapsul, 1999, 16(2): 205-13.
[6] Duchene D, Ponchel G, Denis W. Cyclodextrins in targeting appli cation to nanoparticles [J]. Adv Drug Delve Rev, 1999, 36(3): 29-40.
[7] Song CX, Labhasetwar V, Murohy H, et al. Formulation and charac terization of biodegradable nanoparticles for intravascular local drug delivery[J]. J Control Release, 1997, 43(5): 197-212.
[8] Niwa T, Takeuchi H, Hino T, et al. Biodegradable subicron carries for peptide drugs: preparation ofDL-PLGA nanoparticles with Naby a novel emulsion-phase separation method in an oil system [J]. Int F Pharm, 1995, 121(1): 45-53.
[9] 常津,刘海峰,姚康德.医用纳米控释系统的研究进展[J].中国生物医学工程学报(Chin JBiomedEng),2000,19(4):423-31.
[10] 黎洪珊,赵京玲,魏树礼.环孢菌素A聚乳酸纳米粒胶体的制备和大鼠的口服吸收[J].中国药学杂志(Chin Pharm J),1999,34(8):532-6.
[11] 皮洪琼,吴俊丽,袁直,等.注射用生物可降解胰岛素纳米球的制备[J].应用化学,2001,18(5):365-9.
[12] 中华人民共和国卫生部药典委员会编.药典注释[M].北京:化学工业出版社,1990.209-11. |
